About: Unicycive Therapeutics, Inc., a clinical-stage biotechnology company, identifies, develops, and commercializes therapies for the treatment of kidney diseases in the United States. It develops oxylanthanum carbonate, a lanthanum-based phosphate binding agent, which is for the treatment of hyperphosphatemia in patients with chronic kidney disease on dialysis; and UNI-494, a nicotinamide ester derivative and a selective ATP-sensitive mitochondrial potassium channel activator, which is in Phase I clinical trial for the treatment of acute kidney injury and pre-clinical stage for the treatment of chronic kidney disease. The company was incorporated in 2016 and is headquartered in Mountain View, California.
Sector: Healthcare
Industry: Biotechnology
Latest price: $3.82 (+1.46%)
UNCY NASDAQ Unicycive Therapeutics Inc
Unicycive Therapeutics Inc share price
Atividade de preço de UNCY
Último preço
$ 3,820
Variação (24h)
0,06 USD (1,46%)
Volume
820.56K
Volume (média 4 sem.)
-
Abertura
$ 3,82
Variação do dia
$ 3,74 - $ 3,87
Fechamento anterior
$ 3,76
Último negócio
29 Oct, 8:00 pm GMT+0
Atrasado
29 Oct, 8:00 pm GMT+0
UNCY price performance
Atrasado
29 Oct, 8:00 pm GMT+0
quote.marketSignals